valproic acid has been researched along with Dyspnea in 6 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Dyspnea: Difficult or labored breathing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Since the emergence of coronavirus disease 2019 (COVID-19), neurological symptoms, syndromes, and complications associated with this multi-organ viral infection have been reported and the various aspects of neurological involvement are increasingly uncovered." | 2.72 | Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. ( Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M, 2021) |
| "Finally, we made the diagnosis of eosinophilic pneumonia secondary to sodium divalproate." | 1.56 | [Eosinophilic pneumonia: A rare complication of sodium divalproate]. ( Chabot, F; Chaouat, A; Faure, M; Gomez, E; Petit, I; Petitpain, N; Ruuth-Praz, J, 2020) |
| " At the time of deterioration, serum valproate was at toxic level in the three reported cases." | 1.32 | Delayed toxicity following acute ingestion of valpromide. ( Descotes, J; Frantz, P; Martin, O; Moulsma, M; Parant, F; Payen, C; Pulce, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ruuth-Praz, J | 1 |
| Faure, M | 1 |
| Gomez, E | 1 |
| Petit, I | 1 |
| Petitpain, N | 1 |
| Chaouat, A | 1 |
| Chabot, F | 1 |
| Emamikhah, M | 1 |
| Babadi, M | 1 |
| Mehrabani, M | 1 |
| Jalili, M | 1 |
| Pouranian, M | 1 |
| Daraie, P | 1 |
| Mohaghegh, F | 1 |
| Aghavali, S | 1 |
| Zaribafian, M | 1 |
| Rohani, M | 1 |
| Taşer, N | 1 |
| Sarıkaya, M | 1 |
| San Miguel López de Uralde, SM | 1 |
| Prieto Peraita, M | 1 |
| Blanco Bengoechea, EJ | 1 |
| Payen, C | 1 |
| Frantz, P | 1 |
| Martin, O | 1 |
| Parant, F | 1 |
| Moulsma, M | 1 |
| Pulce, C | 1 |
| Descotes, J | 1 |
1 review available for valproic acid and Dyspnea
| Article | Year |
|---|---|
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; | 2021 |
5 other studies available for valproic acid and Dyspnea
| Article | Year |
|---|---|
[Eosinophilic pneumonia: A rare complication of sodium divalproate].
Topics: Bipolar Disorder; Dyspnea; Female; Humans; Iatrogenic Disease; Middle Aged; Pulmonary Eosinophilia; | 2020 |
An unusual case of pleuropericardial neutrophilic effusion associated with valproate.
Topics: Adult; Cough; Dyspnea; Echocardiography; Epilepsy; Female; Humans; Pericardial Effusion; Pericardioc | 2015 |
[Pulmonary eosinophilia associated with valproic acid].
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Anxiety Disorders; Bronchoalveolar Lavage Flu | 2015 |
Delayed toxicity following acute ingestion of valpromide.
Topics: Adult; Anticonvulsants; Coma; Dyspnea; Female; Hepatic Encephalopathy; Humans; Male; Prodrugs; Time | 2004 |
Adverse Drug Reactions Advisory Committee: ADRAC report for 1980.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Australia; Bronchial Spasm; Chemical and Drug Induced Live | 1982 |